Choroidal neovascularisation in pathological myopia: an update in management
- PMID: 16234465
- PMCID: PMC1772951
- DOI: 10.1136/bjo.2005.074716
Choroidal neovascularisation in pathological myopia: an update in management
Abstract
Choroidal neovascularisation (CNV) secondary to pathological myopia is an important cause of significant visual impairment in young and middle aged adults globally and is particularly prevalent in Asian populations. In the past few years, there have been rapid advancements in the different treatments for myopic CNV. The purpose of this perspective is to give an overview of the natural history of myopic CNV and the various treatment options including laser photocoagulation, photodynamic therapy, sub-macular surgery, and macular translocation surgery. Future directions in the management of myopic CNV are also discussed.
References
-
- Curtin BJ, Karlin DB. Axial length measurement and fundus changes of the myopic eyes. Am J Ophthalmol 1971;71:42–50. - PubMed
-
- Noble KG, Carr RE. Pathologic myopia. Ophthalmology 1982;89:1099–100. - PubMed
-
- Lin LL, Shih YF, Hsiao CK, et al. Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore 2004;33:27–33. - PubMed
-
- Wong TY, Foster PJ, Hee J, et al. Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci 2000;41:2486–94. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous